IHE iShares Dow Jones U.S. Pharmaceutical Index Fund ETF

Seeks to track, before fees and expenses, the Dow Jones U.S. Select Pharmaceuticals Index. The Index is designed to measure the performance of U.S. companies in the pharmaceuticals sector using the ICB classification system. A nonconstituent company must have float-adjusted market capitalization of at least $500 million to enter the Index.

$185.81  -1.06 (-0.57%)
As of 12/06/2021 15:10:34 EST     IEX book   CBOE book


ETF Information
Sponsor:     iShares
Category1:  US Equity
Category2:  Single industry
Category3:  Healthcare
Morningstar category:  Health
Leverage factor:  1.00
Inception date:  05/01/2006
Index tracking method: Passive replication
Current yield:  1.45%
Historical average yield:  1.37%
Market cap:  $374,240,000
Average volume:  5,389
Fees:     0.4300%

Index Information
Dow Jones U.S. Select Pharmaceuticals Index
Index symbol:  DJSPHM
Provider:   S&P Dow Jones
Index weighting:   Market capitalization
Index inception date:  04/28/2006
Backtesting data exists:   Yes
Number of holdings:  42  (as of 11/30/2017)

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy